HIGHLIGHTS
- who: Todryk and collaborators from the (UNIVERSITY) have published the article: Revisiting the Elusive Hepatitis C Vaccine Author, in the Journal: Vaccines 2021, 9, 114. of 25/01/2021
- future: It may be that the antigenic component needs to better match the HCV variants in circulation and that more studies of these heterogenous HCV particles are required in fasted individuals who resolve acute infection in parallel with characterising their immune_response.
SUMMARY
Most of the proteins that HCV possesses are potential antigen candidates that could be incorporated into a vaccine proteins, and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.